This activity is intended for women's health clinicians/obstetricians/gynecologists, family medicine practitioners, internists, nurses, pharmacists, urologists, and other members of the health care team for patients with urinary tract infection.
The goal of this activity is to describe rural-urban differences in temporal trends and risk for inappropriate antibiotic use by agent and duration among women with uncomplicated urinary tract infection, based on an observational cohort study using the IBM MarketScan Commercial Database (2010-2015).
Upon completion of this activity, participants will:
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-21-290-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 4/16/2021
Valid for credit through: 4/16/2022, 11:59 PM EST
processing....
Appropriate antibiotic prescribing as recommended by current guidelines is important for clinical and public health, as inappropriate antibiotic use is linked to increased risk for treatment failure, adverse events, antibiotic resistance, and healthcare costs. However, most antibiotic prescriptions for uncomplicated urinary tract infections (UTIs) are written for nonrecommended agents and durations and are therefore suboptimal.
The US Department of Health and Human Services prioritizes leveling of rural health disparities, but how these affect antibiotic treatment for UTIs has been previously undetermined.
Women living in rural areas were significantly more likely than those in urban areas to receive inappropriate antibiotic prescriptions for UTIs, based on data from an observational cohort study of more than 600,000 women.
Uncomplicated UTIs are common among otherwise healthy women in the United States, and certain antibiotics are recommended as first-line therapy, write Abbye W. Clark, MD, from Washington University, St. Louis, and colleagues.
"However, most antibiotic prescriptions for uncomplicated UTIs are suboptimal because they are written for nonrecommended agents and durations," they note.
Addressing rural health disparities has become a focus in the United States, and previous studies of respiratory tract infections have shown differences in antibiotic prescribing based on geographic region; "however, no large-scale studies have evaluated rural-urban differences in inappropriate outpatient antibiotic prescribing for UTIs," they add.
In a study published in Infection Control & Hospital Epidemiology, the researchers identified 670,450 women aged 18-44 years who received oral antibiotics for uncomplicated UTIs between 2010 and 2015, using a commercial insurance database to determine diagnosis and antibiotic prescription information. Women were defined as urban if they lived in a metropolitan statistical area of at least 50,000 inhabitants (86.2%); all other women were defined as rural (13.8%). The median age was 30 years for both groups.
Overall, 46.7% of the women received prescriptions for inappropriate antibiotics and 76.1% received antibiotics for inappropriate durations.
Antibiotics and durations were defined as appropriate or inappropriate based on current clinical guidelines. "We classified first-line agents (nitrofurantoin, trimethoprim-sulfamethoxazole [TMP-SMX], and fosfomycin) as appropriate and non-first-line agents (fluoroquinolones and β-lactams) as inappropriate," the researchers write.
The regimens classified as appropriate duration were "nitrofurantoin 5-day regimen, TMP-SMX (including TMP monotherapy) 3-day regimen, fosfomycin 1-day regimen, fluoroquinolones 3-day regimen, and β-lactams 3-7-day regimens. All other regimens were classified as inappropriate duration," they note.
More Rural Women Receive Long-Duration Antibiotics
In a multivariate analysis, similar percentages of antibiotics for rural and urban women consisted of inappropriate agents (45.9% vs 46.9%, respectively) including use of fluoroquinolones (41.0% vs 41.7%) and β-lactams (4.8% vs 5.0%).
However, across all antibiotics, women in rural areas were more likely than women in urban areas to receive prescriptions for inappropriate durations (83.9% vs 74.9%; adjusted risk ratio, 1.10).
The percentage of women who received inappropriate antibiotic agents was not significantly different according to geographic region of the country.
From 2011 to 2015, the quarterly proportion of women overall who received inappropriate agents and antibiotics for inappropriate durations decreased slightly (from 48.5% to 43.7% and from 78.3% to 73.4%, respectively), the researchers note.
The study findings were limited by several factors including the potentially lenient definition of antibiotic duration, a study population that disproportionately oversampled from the South and undersampled from the West, use of ZIP codes to determine rural vs urban status, lack of data on race and income, and lack of access to urine culture results, the researchers note.
However, "our study identified rural-urban differences in antibiotic prescribing, including an actionable disparity in the duration of antibiotics that disproportionately affects women who live in rural locations," they write.
"Given the large quantity of inappropriate prescriptions annually in the United States, as well as the negative patient- and society-level consequences of unnecessary exposure to antibiotics, antimicrobial stewardship interventions are needed to improve outpatient UTI antibiotic prescribing, particularly in rural settings," they conclude.
Data Support Need for Education and Stewardship
"This manuscript provides valuable information to all women's health providers regarding the importance of antibiotic stewardship," David M. Jaspan, DO, and Natasha Abdullah, MD, from the Einstein Medical Center, Philadelphia, said in an interview. Whether urban or rural, more than 45% of the patients received inappropriate non-first-line treatment and 76% of the prescriptions were for an inappropriate duration (98.8% for longer durations than recommended, 1.2% for shorter durations), they emphasized.
"The potential negative impact of antibiotic resistance, coupled with the potential for increased side effects, should prompt providers to ensure that when treating uncomplicated UTIs in women, that the choice of treatment and the duration of treatment is tailored to the patient's needs," Dr. Jaspan and Dr. Abdullah said.
To improve antibiotic prescribing, especially at the local and regional level, "We encourage providers to familiarize themselves with local information as it pertains to known resistance when prescribing empiric treatment regimens for uncomplicated UTIs," they said.
The study was supported by the National Center for Advancing Translational Sciences at the National Institutes of Health. Lead author Dr Clark, as well as Dr Jaspan and Dr Abdullah, had no financial conflicts to disclose.
Infect Control Hosp Epidemiol. Published online February 24, 2021.[1]